Chief Medical Officer Golden Lee Scott sold 10,000 shares at $63.38, holding 79,944 post-sale; stock down -20.7% from 52-week high
Golden Lee Scott, EVP & Chief Medical Officer, sold 10,000 shares at $63.38 on 2026-03-05, reducing holdings by -11.1% to 79,944 shares. The stock is currently trading at $68.40, down -8.4% over 30 days and -20.7% from its 52-week high of $86.25. Despite the recent weakness, PTCT's fundamentals remain robust: FY revenue growth reached +114.5% year-over-year with $211.0M quarterly revenue and $15.9M net income, yielding a P/E of 3.15 and market cap of $5.7B. The transaction's significance is moderated by the absence of timing patterns or stated scheduling information that would clarify strategic intent; investors should monitor whether this represents a measured position reduction amid otherwise strong operating metrics or signals management concern about near-term performance.